Date printed: 21/02/2019
Adacel
Details for Adacel vaccine and its components.
Sponsor:
Sanofi-Aventis Australia
Administration route:
Intramuscular injection
Vaccine group:
Combination vaccines
Registered as a booster in people aged ≥10 years.
dTpa — diphtheria-tetanus-acellular pertussis combination vaccine (reduced antigen formulation)
Each 0.5 mL monodose vial contains:
- ≥2 IU diphtheria toxoid
- ≥20 IU tetanus toxoid
- 2.5 µg pertussis toxoid
- 5 µg filamentous haemagglutinin
- 3 µg pertactin
- 5 µg pertussis fimbriae types 2 and 3
- 0.33 mg aluminium as aluminium phosphate
- 0.6% v/v phenoxyethanol
Also contains traces of:
- formaldehyde
- glutaraldehyde
The product information and consumer medicine information for Adacel have more details.
Page history
Last updated:
4 June 2018
Last reviewed:
4 June 2018
Definitions
- dTpa
- diphtheria-tetanus-acellular pertussis vaccine, reduced antigen content formulation
- IU
- international units
This document was printed on: 23/02/2019. Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/vaccines/adacel.